Cerebral blood flow and glucose metabolism in healthy volunteers measured using a high-resolution PET scanner

Marc C Huisman, Larissa W van Golen, Nikie J Hoetjes, Henri N Greuter, Patrick Schober, Richard G Ijzerman, Michaela Diamant, Adriaan A Lammertsma, Marc C Huisman, Larissa W van Golen, Nikie J Hoetjes, Henri N Greuter, Patrick Schober, Richard G Ijzerman, Michaela Diamant, Adriaan A Lammertsma

Abstract

Background: Positron emission tomography (PET) allows for the measurement of cerebral blood flow (CBF; based on [15O]H2O) and cerebral metabolic rate of glucose utilization (CMRglu; based on [18 F]-2-fluoro-2-deoxy-d-glucose ([18 F]FDG)). By using kinetic modeling, quantitative CBF and CMRglu values can be obtained. However, hardware limitations led to the development of semiquantitive calculation schemes which are still widely used. In this paper, the analysis of CMRglu and CBF scans, acquired on a current state-of-the-art PET brain scanner, is presented. In particular, the correspondence between nonlinear as well as linearized methods for the determination of CBF and CMRglu is investigated. As a further step towards widespread clinical applicability, the use of an image-derived input function (IDIF) is investigated.

Methods: Thirteen healthy male volunteers were included in this study. Each subject had one scanning session in the fasting state, consisting of a dynamic [15O]H2O scan and a dynamic [18 F]FDG PET scan, acquired at a high-resolution research tomograph. Time-activity curves (TACs) were generated for automatically delineated and for manually drawn gray matter (GM) and white matter regions. Input functions were derived using on-line arterial blood sampling (blood sampler derived input function (BSIF)). Additionally, the possibility of using carotid artery IDIFs was investigated. Data were analyzed using nonlinear regression (NLR) of regional TACs and parametric methods.

Results: After quality control, 9 CMRglu and 11 CBF scans were available for analysis. Average GM CMRglu values were 0.33 ± 0.04 μmol/cm3 per minute, and average CBF values were 0.43 ± 0.09 mL/cm3 per minute. Good correlation between NLR and parametric CMRglu measurements was obtained as well as between NLR and parametric CBF values. For CMRglu Patlak linearization, BSIF and IDIF derived results were similar. The use of an IDIF, however, did not provide reliable CBF estimates.

Conclusion: Nonlinear regression analysis, allowing for the derivation of regional CBF and CMRglu values, can be applied to data acquired with high-spatial resolution current state-of-the-art PET brain scanners. Linearized models, applied to the voxel level, resulted in comparable values. CMRglu measurements do not require invasive arterial sampling to define the input function.

Trial registration: ClinicalTrials.gov NCT00626080.

Figures

Figure 1
Figure 1
Correlation between Patlak- and NLR-derived Kivalues. Data of all 16 gray matter regions and a white matter brain region of nine healthy subjects are presented. Data points for each individual subject are shown with a separate symbol. The solid line indicates the line of identity.
Figure 2
Figure 2
Correlation of average Kivalues derived using parametric and regional Patlak analyses. Data of all 16 total gray matter regions and a white matter brain region are presented for nine subjects. Parametric values represent the mean of all voxels within an ROI. The solid line indicates the line of identity. Results for both images without smoothing (black dots) and those smoothed with a 6-mm Gaussian filter (white dots) are shown.
Figure 3
Figure 3
Representative parametric images of a single subject. The CBF image (upper panel) and the CMRglu image (lower panel) of the same subject are presented. The parametric CBF image was generated after smoothing with a 6-mm Gaussian filter.
Figure 4
Figure 4
Correlation of CBF values derived using parametric (basis function method) and regional (NLR) analyses. Data of 16 gray matter regions and a white matter region are shown for 11 subjects. Parametric values represent the mean of all voxels within an ROI. Data points for each individual subject are shown with a separate symbol. The solid line indicates the line of identity.
Figure 5
Figure 5
Correlation between IDIF- and BSIF-based NLR-derived Kivalues. The correlation is for 16 gray matter regions and a white matter region. Data points for each individual subject (n = 9) are shown with the same symbol. The solid line indicates the line of identity.
Figure 6
Figure 6
Correlation between IDIF- and BSIF-based Patlak-derived Kivalues. The correlation is for 16 gray matter regions and a white matter region. Data points for each individual subject (n = 9) are shown with the same symbol. The solid line indicates the line of identity.

References

    1. Lammertsma AA, Brooks DJ, Frackowiak RS, Beaney RP, Herold S, Heather JD, Palmer AJ, Jones T. Measurement of glucose utilization with [18 F]2-fluoro-2-deoxy-D-glucose: a comparison of different analytical methods. J Cereb Blood Flow Metab. 1987;7:161–172. doi: 10.1038/jcbfm.1987.39.
    1. Schmidt KC, Lucignani G, Sokoloff L. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination. J Nucl Med. 1996;37:394–399.
    1. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol. 1980;238:E69–E82.
    1. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371–388. doi: 10.1002/ana.410060502.
    1. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L. The [18 F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979;44:127–137. doi: 10.1161/01.RES.44.1.127.
    1. Sokoloff L, Reivich M, Kennedy C, Des Rosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem. 1977;28:897–916. doi: 10.1111/j.1471-4159.1977.tb10649.x.
    1. Wienhard K, Pawlik G, Herholz K, Wagner R, Heiss WD. Estimation of local cerebral glucose utilization by positron emission tomography of [18 F]2-fluoro-2-deoxy-D-glucose: a critical appraisal of optimization procedures. J Cereb Blood Flow Metab. 1985;5:115–125. doi: 10.1038/jcbfm.1985.15.
    1. Yu AS, Lin HD, Huang SC, Phelps ME, Wu HM. Quantification of cerebral glucose metabolic rate in mice using 18 F-FDG and small-animal PET. J Nucl Med. 2009;50:966–973. doi: 10.2967/jnumed.108.060533.
    1. Frackowiak R, Lenzi G, Jones T, Heather J. Quantitative measurement of regional cerebral blood flow and oxygen metabolism in man using 15O and positron emission tomography: theory, procedure, and normal values. J Comput Assist Tomogr. 1980;6:727–736.
    1. Herscovitch P, Raichle ME. Effect of tissue heterogeneity on the measurement of cerebral blood flow with the equilibrium C15O2 inhalation technique. J Cereb Blood Flow Metab. 1983;3:407–415. doi: 10.1038/jcbfm.1983.66.
    1. Koeppe RA, Holden JE, Ip WR. Performance comparison of parameter estimation techniques for the quantitation of local cerebral blood flow by dynamic positron computed tomography. J Cereb Blood Flow Metab. 1985;5:224–234. doi: 10.1038/jcbfm.1985.29.
    1. Lammertsma AA, Cunningham VJ, Deiber MP, Heather JD, Bloomfield PM, Nutt J, Frackowiak RS, Jones T. Combination of dynamic and integral methods for generating reproducible functional CBF images. J Cereb Blood Flow Metab. 1990;10:675–686. doi: 10.1038/jcbfm.1990.121.
    1. Silverman DH, Phelps ME. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. Mol Genet Metab. 2001;74:128–138. doi: 10.1006/mgme.2001.3236.
    1. de Jong HW, van Velden FH, Kloet RW, Buijs FL, Boellaard R, Lammertsma AA. Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner. Phys Med Biol. 2007;52:1505–1526. doi: 10.1088/0031-9155/52/5/019.
    1. Heiss WD, Habedank B, Klein JC, Herholz K, Wienhard K, Lenox M, Nutt R. Metabolic rates in small brain nuclei determined by high-resolution PET. J Nucl Med. 2004;45:1811–1815.
    1. Borghammer P, Hansen SB, Eggers C, Chakravarty M, Vang K, Aanerud J, Hilker R, Heiss WD, Rodell A, Munk OL, Keator D, Gjedde A. Glucose metabolism in small subcortical structures in Parkinson's disease. Acta Neurol Scand. 2012;125:303–310.
    1. Walker MD, Feldmann M, Matthews JC, Anton-Rodriguez JM, Wang S, Koepp MJ, Asselin MC. Optimization of methods for quantification of rCBF using high-resolution [(15)O]H(2)O PET images. Phys Med Biol. 2012;57:2251–2271. doi: 10.1088/0031-9155/57/8/2251.
    1. Mourik JE, van Velden FH, Lubberink M, Kloet RW, van Berckel BN, Lammertsma AA, Boellaard R. Image derived input functions for dynamic High Resolution Research Tomograph PET brain studies. Neuroimage. 2008;43:676–686. doi: 10.1016/j.neuroimage.2008.07.035.
    1. Mourik JE, Lubberink M, Klumpers UM, Comans EF, Lammertsma AA, Boellaard R. Partial volume corrected image derived input functions for dynamic PET brain studies: methodology and validation for [11C]flumazenil. Neuroimage. 2008;39:1041–1050. doi: 10.1016/j.neuroimage.2007.10.022.
    1. Zanotti-Fregonara P, Chen K, Liow JS, Fujita M, Innis RB. Image-derived input function for brain PET studies: many challenges and few opportunities. J Cereb Blood Flow Metab. 2011;31:1986–1998. doi: 10.1038/jcbfm.2011.107.
    1. Mourik JE, Lubberink M, Lammertsma AA, Boellaard R. Image derived input functions: effects of motion on tracer kinetic analyses. Mol Imaging Biol. 2011;13:25–31. doi: 10.1007/s11307-010-0301-5.
    1. Boellaard R, Van LA, Van-Balen SC, Hoving BG, Lammertsma AA. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET. Eur J Nucl Med. 2001;28:81–89. doi: 10.1007/s002590000405.
    1. Hong IK, Chung ST, Kim HK, Kim YB, Son YD, Cho ZH. Ultra fast symmetry and SIMD-based projection-backprojection (SSP) algorithm for 3-D PET image reconstruction. IEEE Trans Med Imaging. 2007;26:789–803.
    1. van Velden FH, Kloet RW, van Berckel BN, Lammertsma AA, Boellaard R. Accuracy of 3-dimensional reconstruction algorithms for the high-resolution research tomograph. J Nucl Med. 2009;50:72–80.
    1. Cizek J, Herholz K, Vollmar S, Schrader R, Klein J, Heiss WD. Fast and robust registration of PET and MR images of human brain. Neuroimage. 2004;22:434–442. doi: 10.1016/j.neuroimage.2004.01.016.
    1. Svarer C, Madsen K, Hasselbalch SG, Pinborg LH, Haugbol S, Frokjaer VG, Holm S, Paulson OB, Knudsen GM. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage. 2005;24:969–979. doi: 10.1016/j.neuroimage.2004.10.017.
    1. Loening AM, Gambhir SS. AMIDE: a free software tool for multimodality medical image analysis. Mol Imaging. 2003;2:131–137. doi: 10.1162/153535003322556877.
    1. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab. 1983;3:1–7. doi: 10.1038/jcbfm.1983.1.
    1. Reivich M, Alavi A, Wolf A, Fowler J, Russell J, Arnett C, MacGregor RR, Shiue CY, Atkins H, Anand A. Glucose metabolic rate kinetic model parameter determination in humans: the lumped constants and rate constants for [18 F]fluorodeoxyglucose and [11C]deoxyglucose. J Cereb Blood Flow Metab. 1985;5:179–192. doi: 10.1038/jcbfm.1985.24.
    1. Boellaard R, Knaapen P, Rijbroek A, Luurtsema GJ, Lammertsma AA. Evaluation of basis function and linear least squares methods for generating parametric blood flow images using 15O-water and positron emission tomography. Mol Imaging Biol. 2005;7:273–285. doi: 10.1007/s11307-005-0007-2.
    1. Brooks DJ, Gibbs JS, Sharp P, Herold S, Turton DR, Luthra SK, Kohner EM, Bloom SR, Jones T. Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [11C]3-O-methyl-d-glucose and positron emission tomography. J Cereb Blood Flow Metab. 1986;6:240–244. doi: 10.1038/jcbfm.1986.37.
    1. Duckrow RB. Glucose transfer into rat brain during acute and chronic hyperglycemia. Metab Brain Dis. 1988;3:201–209. doi: 10.1007/BF00999236.
    1. Ziegler D, Langen KJ, Herzog H, Kuwert T, Muhlen H, Feinendegen LE, Gries FA. Cerebral glucose metabolism in type 1 diabetic patients. Diabet Med. 1994;11:205–209. doi: 10.1111/j.1464-5491.1994.tb02021.x.
    1. Wilson PD, Huang SC, Hawkins RA. Single-scan Bayes estimation of cerebral glucose metabolic rate: comparison with non-Bayes single-scan methods using FDG PET scans in stroke. J Cereb Blood Flow Metab. 1988;8:418–425. doi: 10.1038/jcbfm.1988.78.
    1. Hasselbalch SG, Knudsen GM, Capaldo B, Postiglione A, Paulson OB. Blood–brain barrier transport and brain metabolism of glucose during acute hyperglycemia in humans. J Clin Endocrinol Metab. 2001;86:1986–1990. doi: 10.1210/jc.86.5.1986.
    1. Knudsen GM. Application of the double-indicator technique for measurement of blood–brain barrier permeability in humans. Cerebrovasc Brain Metab Rev. 1994;6:1–30.

Source: PubMed

3
구독하다